This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Megumi Kunou: Innovator in Biochemical Patents
Introduction
Megumi Kunou is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biochemistry, particularly through her innovative patent work. Her research focuses on the development of novel compounds that have potential applications in medicine and biotechnology.
Latest Patents
One of Megumi Kunou's notable patents is for a galactosamine substitute of poly-.omega.-substituted-L-glutamic acid. This invention involves a polypeptide that includes a recurring unit represented by a specific formula. The polypeptide is characterized by the substitution of part or all of the peptide with an .omega.-galactosamyl-L-glutamic acid residue. This innovative approach has implications for enhancing the efficacy of therapeutic agents.
Career Highlights
Megumi Kunou is associated with Yamanouchi Pharmaceutical Company Ltd., where she has been instrumental in advancing research and development initiatives. Her work has not only contributed to the company's portfolio but has also positioned her as a key figure in the pharmaceutical industry.
Collaborations
Throughout her career, Megumi has collaborated with esteemed colleagues, including Ichirou Kitada and Toshihiro Akaike. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Megumi Kunou's contributions to the field of biochemistry through her patent work exemplify her dedication to innovation. Her research continues to pave the way for advancements in medical applications, showcasing the importance of inventors in driving progress in science and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile